SRF , the specialty chemicals company, continues to face headwinds as Citi Research maintains its cautious stance on the stock. The global brokerage has reiterated its 'Sell' rating while making a downward revision to its price target.

Revised Price Target and Rating

Citi has reduced its target price for SRF to ₹2,575 while maintaining the 'Sell' rating. The price target revision indicates the brokerage's measured outlook on the company's valuation prospects.

Analyst Outlook

The maintained 'Sell' rating combined with the reduced target price reflects Citi's continued cautious approach toward SRF. The brokerage's decision to lower the price target suggests a reassessment of the company's valuation metrics and growth prospects.

The recommendation forms part of Citi's broader coverage of the specialty chemicals sector, where the brokerage evaluates companies based on various fundamental and technical parameters. SRF operates in the specialty chemicals space, which has seen varied performance across different segments and market conditions.

SRF Limited has announced the re-appointment of Mr. Pramod Gopaldas Gujarathi as Director (Safety & Environment) & Occupier, extending his tenure for another three years. The decision reflects the company's commitment to maintaining experienced leadership in critical safety and environmental functions.

Board Approval and Timeline

The Board of Directors approved the re-appointment on January 20, 2026, following recommendations from the Nomination and Remuneration Committee. The appointment details are structured as follows:

Leadership Profile and Experience

Mr. Gujarathi brings substantial expertise to his role, with qualifications and experience spanning nearly five decades in the industry. His professional background includes:

• Age: 73 years
• Education: B.Tech (Chemical Engineering) from IIT Bombay, Post Graduate Diploma in Management Studies
• Total Experience: 47 years in production, engineering, safety, environment, QA and R&D
• Previous Role: Director & Site Manager with Bayer Group for approximately 18 years

Regulatory Compliance

The re-appointment follows all regulatory requirements under Regulation 30 of the SEBI Listing Regulations and SEBI Master Circular No. SEBI/HO/CFD/PoD2/CIR/P/0155 dated November 11, 2024. The company has confirmed that Mr. Gujarathi is not debarred from holding the office of Director by virtue of any SEBI Order or other regulatory authority.

Shareholder Approval Process

The re-appointment remains subject to approval by the company's members at the forthcoming Annual General Meeting. This standard governance procedure ensures shareholder participation in key leadership decisions, particularly for specialized roles such as Director (Safety & Environment) & Occupier.

The seamless transition planned for April 1, 2026, ensures continuity in SRF's safety and environmental oversight functions, with Mr. Gujarathi's extensive experience providing valuable leadership in these critical operational areas.